Lee, H.K.; Kim, C.-W.; Ahn, D.; Go, R.-E.; Choi, Y.; Choi, K.-C.
Next-Generation Antisense Oligonucleotide of TGF-β2 Enhances T Cell-Mediated Anticancer Efficacy of Anti-PD-1 Therapy in a Humanized Mouse Model of Immune-Excluded Melanoma. Cancers 2022, 14, 5220.
https://doi.org/10.3390/cancers14215220
AMA Style
Lee HK, Kim C-W, Ahn D, Go R-E, Choi Y, Choi K-C.
Next-Generation Antisense Oligonucleotide of TGF-β2 Enhances T Cell-Mediated Anticancer Efficacy of Anti-PD-1 Therapy in a Humanized Mouse Model of Immune-Excluded Melanoma. Cancers. 2022; 14(21):5220.
https://doi.org/10.3390/cancers14215220
Chicago/Turabian Style
Lee, Hong Kyu, Cho-Won Kim, Dohee Ahn, Ryeo-Eun Go, Youngdong Choi, and Kyung-Chul Choi.
2022. "Next-Generation Antisense Oligonucleotide of TGF-β2 Enhances T Cell-Mediated Anticancer Efficacy of Anti-PD-1 Therapy in a Humanized Mouse Model of Immune-Excluded Melanoma" Cancers 14, no. 21: 5220.
https://doi.org/10.3390/cancers14215220
APA Style
Lee, H. K., Kim, C. -W., Ahn, D., Go, R. -E., Choi, Y., & Choi, K. -C.
(2022). Next-Generation Antisense Oligonucleotide of TGF-β2 Enhances T Cell-Mediated Anticancer Efficacy of Anti-PD-1 Therapy in a Humanized Mouse Model of Immune-Excluded Melanoma. Cancers, 14(21), 5220.
https://doi.org/10.3390/cancers14215220